The Kansas Institute for Precision Medicine: IsoPlexis IsoSpark

堪萨斯精准医学研究所:IsoPlexis IsoSpark

基本信息

  • 批准号:
    10806784
  • 负责人:
  • 金额:
    $ 16.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-02-15 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The long-term goal of the Kansas Institute for Precision Medicine (KIPM) is to develop a multi-disciplinary research environment focused on the theme of precision medicine that will advance healthcare through innovative scientific discoveries. This will be accomplished through this Phase I COBRE program, which will develop an innovative training paradigm of physician/scientists that is fortified by an experienced set of directors and mentors with experiences in biomedical research, state-of-the-art research cores, and an organizational structure all built around the precision medicine theme. This KIPM COBRE will be led by Andrew K. Godwin, PhD (Director), Steven A. Soper, PhD (Associate Director), and Alan S.L. Yu, MB, B. Chir (Director of Mentoring and Career Development) and will train promising young scientists under the auspices of precision medicine. The Administrative Core will be responsible for the overall management of the administrative, fiscal, and scientific aspects of KIPM. This Core will play an important leadership role in the COBRE program by setting the overall scientific direction of KIPM’s activities, coordinating, and integrating all of the KIPM’s functions, establishing and delineating areas of research emphasis, and promoting internal and external collaborative interactions. Dr. Godwin will have primary administrative oversight of the COBRE through the Administrative Core, but all KIMP activities will be managed and evaluated jointly by the three principal investigators. The specific aims of the Administrative Core will be to: 1) provide administrative leadership and coordinate the research effort by providing the appropriate financial accounting, clerical and other program management support; 2) design and implement a mentoring and career development plan for junior faculty members; 3) convene an internal and an external advisory committee to evaluate the KIPM COBRE; 4) administer and evaluate a research pilot project program; and 5) develop training and infrastructure for patient and community engagement and implementation of precision medicine in primary care practices. These activities will be assisted by Ms. Jessica Leib, who will meet regularly with each of the COBRE faculty to review their available funding and track expenditures. Additionally, she will help administer the fiscal accounting for all the proposed pilot projects, coordinate meetings, travel and activities for the external faculty mentors, the internal and external advisory board members, patient advocates, and members of the Patient and Community Engagement (PACE) Council. Overall, the proposed KIPM COBRE Administrative Core will promote and strengthen interactions between the COBRE and the parent institution by interfacing its activities with other programs, centers, and institutes at KUMC, and by integrating the biomedical research cores with existing institutional shared resource centers.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ANDREW K. GODWIN其他文献

ANDREW K. GODWIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ANDREW K. GODWIN', 18)}}的其他基金

The Kansas Institute for Precision Medicine : Zeiss Axioscan 7
堪萨斯精准医学研究所:Zeiss Axioscan 7
  • 批准号:
    10610667
  • 财政年份:
    2022
  • 资助金额:
    $ 16.48万
  • 项目类别:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
卵巢癌细胞外囊泡蛋白质组指纹图谱用于纳米工程微系统的早期检测
  • 批准号:
    10526715
  • 财政年份:
    2021
  • 资助金额:
    $ 16.48万
  • 项目类别:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
卵巢癌细胞外囊泡蛋白质组指纹图谱用于纳米工程微系统的早期检测
  • 批准号:
    10621734
  • 财政年份:
    2021
  • 资助金额:
    $ 16.48万
  • 项目类别:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
卵巢癌细胞外囊泡蛋白质组指纹图谱用于纳米工程微系统的早期检测
  • 批准号:
    10373086
  • 财政年份:
    2021
  • 资助金额:
    $ 16.48万
  • 项目类别:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
卵巢癌细胞外囊泡蛋白质组指纹图谱用于纳米工程微系统的早期检测
  • 批准号:
    10199594
  • 财政年份:
    2021
  • 资助金额:
    $ 16.48万
  • 项目类别:
Integrated exosomes profiling for minimally invasive diagnosis and monitoring of cancer
用于癌症微创诊断和监测的综合外泌体分析
  • 批准号:
    10307656
  • 财政年份:
    2021
  • 资助金额:
    $ 16.48万
  • 项目类别:
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
卵巢癌细胞外囊泡蛋白质组指纹图谱用于纳米工程微系统的早期检测
  • 批准号:
    10737826
  • 财政年份:
    2021
  • 资助金额:
    $ 16.48万
  • 项目类别:
The Kansas Institute for Precision Medicine
堪萨斯精准医学研究所
  • 批准号:
    10582647
  • 财政年份:
    2019
  • 资助金额:
    $ 16.48万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10867199
  • 财政年份:
    2019
  • 资助金额:
    $ 16.48万
  • 项目类别:
Biobanking and Biomarker Validation (BBV) Core
生物样本库和生物标志物验证 (BBV) 核心
  • 批准号:
    10582682
  • 财政年份:
    2019
  • 资助金额:
    $ 16.48万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.48万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了